CYCLO THERAPEUTICS INC
NASDAQ: CYTHW (Cyclo Therapeutics, Inc.)
最近更新时间: 昨天, 11:59AM0.032
0.00 (0.00%)
AIStockmoo 评分
| 价值 60% | -5.0 |
| 盈利能力弱。短期流动性偏紧。现金流为负。 参考 | |
| 来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 | NA |
| 相对估值 参考 | NA |
| 隐含增长 参考 | NA |
| 历史估值 参考 | NA |
| 资本回报 参考 | NA |
| 盈利趋势 参考 | NA |
| 持仓估值 参考 | NA |
| 风险溢价 参考 | NA |
| 市场估值 参考 | NA |
| 时机 | NA |
| 来自我们对走势图的 AI 技术分析。 参考 | NA |
| 趋势强度 参考 | NA |
| 技术形态 参考 | NA |
| K线形态 参考 | NA |
| 中期趋势 参考 | NA |
| 市场情绪 40% | 0.0 |
| 近期没有目标价,因此依据目标价的调整方向。 参考 | |
| 持仓情绪 参考 | NA |
| 新闻情绪 参考 | NA |
| 聪明钱 | NA |
| 内部交易活动 参考 | NA |
| 机构资金流 参考 | NA |
| 空头持仓 参考 | NA |
| 市场和行业状况不佳。 | |
| 市场环境偏谨慎。 参考 | |
| 行业表现优于大市。 | |
| 只有一个支柱有明确读数,评分不变。 | |
| 不计入评分 | |
| 价格波动 参考 | NA |
| 短、中、长期均无明确趋势。 参考 | |
| 支撑与阻力没有明确信号。 参考 | |
| 最终评分 | -3.14 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Cyclo Therapeutics, Inc. | - | - |
相关股票
| 股票 | 市值 | DY | P/E(TTM) | P/B | 评分 |
|---|---|---|---|---|---|
| CYTHW | - | - | - | - | -3.1 |
| ZYBT | 72 M | - | - | 2.13 | -1.7 |
| SHPH | 17 M | - | - | 0.200 | -2.4 |
| CANB | 2 M | - | 0.233 | 33.49 | -1.4 |
| BIOA | - | - | - | 0.680 | -1.9 |
| CLVRW | - | - | - | - | -0.1 |
|
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
投资组合